slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 73,231-73,260
Pages 3,679
Rows per page 30
Component
73,231-73,260 of 110,355
08
Uses a funnel-like decomposition to narrow down from total market to a specific non-digitized opportunity.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations 1 hit
19
The slide uses the term 'flywheel' in the title, though the content is a data table rather than a diagram.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
20
The slide explains the revenue composition (Platform vs Solutions) and defines the Take Rate metric.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
27
Includes a footnote regarding non-recurring share-based listing expenses.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations 1 hit
06
The slide uses a bar chart for historical/projected growth and a donut chart for market segmentation.Genius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations Beat · Market SizeLoop · Why Now1 hit
07
Genius Group | Investor Presentation Deck | 29 slidesGenius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations Beat · Market SizeLoop · Why Now1 hit
16
Uses a timeline-style visualization to contrast segmented traditional education with a continuous, personalized path.Genius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations 1 hit
26
The table includes both audited and unaudited financial data, with a specific note defining the calculation methodology for Adjusted EBITDA.Genius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations Beat · Financials1 hit
28
The slide includes a specific definition of Adjusted EBITDA in the footer.Genius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations Beat · Financials1 hit
07
The slide uses green arrows to emphasize positive growth across all displayed metrics.GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations Beat · Solution1 hit
14
GMS | Investor Conference Presentation Deck | 26 slidesGMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations Beat · Financials1 hit
19
Includes supplemental cash flow disclosures and a non-GAAP reconciliation for free cash flow.GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations 1 hit
20
The table breaks down net sales by organic growth, acquisitions, and FX impact, as well as by product category (Wallboard, Ceilings, Steel Framing, Complementary Products).GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations 1 hit
25
Includes footnotes detailing adjustments for unamortized discounts and deferred financing costs.GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations 1 hit
07
Includes a scatter plot of vintage vs market multiple and a waterfall-style bridge for proceeds.Hipgnosis Songs Fund | Results Presentation Deck | 22 slides · Hipgnosis Songs Fund
Activist deck Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit
16
Includes a specific callout to Goldman Sachs forecasts as the source for growth data.Hipgnosis Songs Fund | Results Presentation Deck | 22 slides · Hipgnosis Songs Fund
Activist deck Investor relations Beat · DesireLoop · Golden Circle1 hit
21
The chart shows a positive correlation between two variables (likely catalogue size/revenue and valuation multiple).Hipgnosis Songs Fund | Results Presentation Deck | 22 slides · Hipgnosis Songs Fund
Activist deck Investor relations 1 hit
08
The slide uses a comparison framework to contrast traditional vs. new product workflows.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations Beat · Market Size1 hit
09
The slide uses a before-after framing to contrast traditional centralized MRI with the decentralized Swoop system.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 1 hit
16
The 2023 figure is marked with an asterisk indicating revenue guidance.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations Beat · Traction1 hit
17
The chart shows a progression from negative margin to positive margin.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations Beat · Traction1 hit
18
The slide uses a bar chart to demonstrate financial discipline and outlines three key areas of investment.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations Beat · Traction1 hit
06
The slide uses a visual comparison to highlight the safety advantage of NXC-201, specifically focusing on neurotoxicity and CRS duration.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
07
Uses a visual icon-grid to represent market expansion from 5% of hospitals to a much broader network.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
08
The slide uses a molecular biology diagram to illustrate the structural difference in the binding domain of the NXC-201 therapy compared to competitors.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
09
Includes comparative bar charts and flow cytometry data.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · InterestLoop · Aha Moment1 hit
10
The slide uses a comparative timeline/chart layout to contrast clinical outcomes of three different therapies.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · InterestLoop · Aha Moment1 hit
12
The slide uses a process flow diagram to connect cellular pathology to clinical symptoms in the heart, liver, and kidneys.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
13
Includes extensive source citations in the footer.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
14
The slide uses a table structure to contrast treatment outcomes and patient growth across three stages of multiple myeloma.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit